You are about to leave the Clinical Value website now.


Protein induced by vitamin K absence or antagonist-II versus alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: A systematic review with meta-analysis

Quick Summary

This study compares the diagnostic capability of Protein induced by vitamin K absence or antagonist-II (PIVKA-II) with alpha-fetoprotein (AFP) for hepatocellular carcinoma (HCC). The study conducted a systematic literature search to identify relevant studies published up to December 20, 2017. A total of 31 studies were included, and the data were analyzed using a random effects model. This meta-analysis indicates that PIVKA-II is better than AFP in terms of the accuracy for diagnosing HCC, regardless of tumor size, patient ethnic group, or HCC etiology.

You May Also Like

13 February 2024

The Pursuit for Better Patient Outcomes – Innovating HCC Management at Siriraj Hospital

Read More
7 November 2023

Value and Challenges for Precision Oncology Realisation in Real World Practice

Read More


Be the first to receive updates, event opportunities, and thought leadership insights.